ConforMIS Inc - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS

Ticker Exchange SIC # Website Latest Ticker
CFMS Nasdaq 3841 http://www.conformis.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for ConforMIS Inc

Rock star Growth Puts Conformis (NASDAQ:CFMS) In A Position To Use Debt - Jun 3rd, 2022 1:01 pm
Conformis Highlights New Clinical Study Findings that Knee Shapes are Highly Individualized and are Not Determined by Identifiers, Including Gender, Body Type, or Ethnicity - May 24th, 2022 12:00 pm
Conformis, Inc. to Participate in the H.C. Wainwright Global Investment Conference - May 10th, 2022 12:00 pm
ConforMIS (CFMS) Reports Q1 Loss, Tops Revenue Estimates - May 4th, 2022 12:25 pm
Conformis Reports First Quarter 2022 Financial Results - May 4th, 2022 11:00 am
SeaSpine Holdings (SPNE) Reports Q1 Loss, Tops Revenue Estimates - May 3rd, 2022 9:45 pm
Conformis, Inc. to Release First Quarter 2022 Financial Results on May 4, 2022 - Apr 11th, 2022 8:30 pm
Conformis, Inc. Appoints Michael Fillion as Chief Operating Officer - Apr 1st, 2022 9:00 pm
Synchrony Financial (SYF) Ties Up to Ease Orthopedic Care - Mar 23rd, 2022 2:55 pm
Conformis Partners with Synchrony to Offer CareCredit Financial Services to Orthopedic Patients - Mar 22nd, 2022 12:00 pm
Conformis, Inc. Appoints Denise Pedulla as Chief Legal Officer and Corporate Secretary - Mar 14th, 2022 8:30 pm
Gary Fischetti nominated to join Conformis’ Board of Directors - Mar 11th, 2022 1:00 pm
Conformis, Inc. Reports Fourth Quarter and Year End 2021 Financial Results - Mar 2nd, 2022 9:05 pm
Conformis Suspends All Distribution Operations and Business Development in Russia - Mar 2nd, 2022 1:00 pm
New Clinical Study Finds Bilateral Knee Patients Prefer Conformis’ Fully Personalized Solution Over Competitive Off-the-Shelf Implants by a Factor of Over 10 to 1 - Feb 28th, 2022 1:00 pm
Conformis iTotal® CR Knee Replacement System Awarded “7A” Performance Rating from the U.K.’s Orthopaedic Data Evaluation Panel - Feb 24th, 2022 1:00 pm
Conformis, Inc. to Participate in Upcoming Investor Conferences - Feb 18th, 2022 9:30 pm
New Strong Sell Stocks for February 14th - Feb 14th, 2022 1:30 pm
Investors in Conformis (NASDAQ:CFMS) have unfortunately lost 89% over the last five years - Feb 13th, 2022 12:28 pm
Smith+Nephew (SNN) to Acquire Orlando-Based Engage Surgical - Jan 26th, 2022 2:10 pm